Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen.

Porzio G, Trapasso T, Martelli S, Sallusti E, Piccone C, Mattei A, Di Stanislao C, Ficorella C, Marchetti P.

Tumori. 2002 Mar-Apr;88(2):128-30.

PMID:
12088252
[PubMed - indexed for MEDLINE]
2.

The management of menopausal sequelae in patients with breast cancer.

Rostom AY.

Clin Oncol (R Coll Radiol). 2001;13(3):174-80. Review.

PMID:
11527291
[PubMed - indexed for MEDLINE]
3.

Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

Jahanzeb M.

Clin Ther. 2007 Aug;29(8):1535-47. Review.

PMID:
17919537
[PubMed - indexed for MEDLINE]
4.

Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.

Carlson RW, Henderson IC.

Breast Cancer Res Treat. 2003;80 Suppl 1:S19-26; discussion S27-8. Review.

PMID:
14535531
[PubMed - indexed for MEDLINE]
5.

Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

Baber R, Hickey M, Kwik M.

Drug Saf. 2005;28(12):1085-100. Review.

PMID:
16329712
[PubMed - indexed for MEDLINE]
6.

Menopause and breast cancer: symptoms, late effects, and their management.

Ganz PA.

Semin Oncol. 2001 Jun;28(3):274-83. Review.

PMID:
11402437
[PubMed - indexed for MEDLINE]
7.

Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.

Perez EA.

Ann Oncol. 2007 Sep;18 Suppl 8:viii26-35. Review.

PMID:
17890211
[PubMed - indexed for MEDLINE]
Free Article
8.

Three years' follow-up from the ATAC trial is sufficient to change clinical practice: a debate.

Aapro MS, Forbes JF.

Breast Cancer Res Treat. 2003;80 Suppl 1:S3-11; discussion S13-8. Review.

PMID:
14535530
[PubMed - indexed for MEDLINE]
9.

Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer.

Moore HC.

Curr Oncol Rep. 2000 Nov;2(6):587-93. Review.

PMID:
11122897
[PubMed - indexed for MEDLINE]
10.

Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?

Trinkaus M, Chin S, Wolfman W, Simmons C, Clemons M.

Oncologist. 2008 Mar;13(3):222-31. doi: 10.1634/theoncologist.2007-0234. Review.

PMID:
18378532
[PubMed - indexed for MEDLINE]
Free Article
11.

Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions.

Desmarais JE, Looper KJ.

Maturitas. 2010 Dec;67(4):296-308. doi: 10.1016/j.maturitas.2010.08.005. Epub 2010 Sep 28. Review.

PMID:
20880642
[PubMed - indexed for MEDLINE]
12.

Black cohosh: an alternative therapy for menopause?

Mahady GB, Fabricant D, Chadwick LR, Dietz B.

Nutr Clin Care. 2002 Nov-Dec;5(6):283-9. Review.

PMID:
12557811
[PubMed - indexed for MEDLINE]
13.

Acupuncture for vasomotor menopausal symptoms: a systematic review.

Cho SH, Whang WW.

Menopause. 2009 Sep-Oct;16(5):1065-73. doi: 10.1097/gme.0b013e3181a48abd. Review.

PMID:
19424092
[PubMed - indexed for MEDLINE]
14.

[Hormone therapy in breast cancer: the end of tamoxifen?].

Delozier T.

Bull Cancer. 2005 Feb;92(2):142-50. Review. French.

PMID:
15749643
[PubMed - indexed for MEDLINE]
15.

Anti-tumor effects of letrozole.

Miller WR, Anderson TJ, Dixon JM.

Cancer Invest. 2002;20 Suppl 2:15-21. Review.

PMID:
12442345
[PubMed - indexed for MEDLINE]
16.

Perspectives in clinical research of acupuncture on menopausal symptoms.

Baumelou A, Liu B, Wang XY, Nie GN.

Chin J Integr Med. 2011 Dec;17(12):893-7. doi: 10.1007/s11655-011-0930-9. Epub 2011 Dec 3. Review.

PMID:
22139540
[PubMed - indexed for MEDLINE]
17.

Tamoxifen: transition from the laboratory to clinical preventive chemosuppression.

Tormey DC.

Cancer Invest. 1988;6(5):597-600. Review. No abstract available.

PMID:
3063339
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk